The effect of CD25/CD123 expression on the B-ALL patient overall survival (OS) revealed that adult B-ALL patients who showed CD25+/CD123+ coexpression (double-positive) had significantly shorter OS as compared to the negative ones (single positive and double negative) (Table 4). Here, IL3RA is linked to acute lymphoblastic leukemia.